ASX:IMMPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Immutep Ltd
$0.051
$0.001 (1.92%)
Day Range
$0.049 – $0.052
52 Week Range
$0.028 – $0.470
Volume
17.03M
Avg Volume (10D)
12.99M
Market Cap
$75.16M
Price Chart
Market Statistics
Open$0.052
Previous Close$0.052
Day High$0.052
Day Low$0.049
52 Week High$0.470
52 Week Low$0.028
Valuation
Market Cap75.16M
Shares Outstanding1.47B
Price to Book0.77
Trading Activity
Volume17.03M
Value Traded859.32K
Bid$0.050 × 170,000
Ask$0.051 × 464,426
Performance
1 Day0.00%
5 Day13.04%
13 Week13.04%
52 Week-76.89%
YTD-87.47%
Technical Indicators
RSI (14)43.79
50-Day SMA$0.058
200-Day SMA$0.232
Latest News
Hot Topics
Weekly Wrap: Shares fall another 2.6% for the week as conflict worsens
ASX 200 slides 2.6% this week to 8,617 as Iran-Israel conflict lifts oil above $100; NST and SYR plunge, while EOS soars on a Middle East contract.
Biotechnology
Immutep doses first patient in Phase II/III efti trial to treat metastatic breast cancer
Biotechnology company Immutep (ASX: IMM) has safely dosed the first patient at a European clinical site for its integrated Phase II/III AIPAC-003 trial to treat metastatic breast cancer. AIPAC-003 is evaluating the company’s soluble LAG-3 protein and first-in-class MHC Class II agonist known as eftilagimod alpha (efti) in combination with standard-of-care paclitaxel for the treatment […]